The Centers for Medicare & Medicaid Services kept a pre-New Year’s resolution by releasing a second draft of the new MDS tool that will be used to assess residents starting Oct. 1, 2023. The agency ...
Myelodysplastic syndrome (MDS) involves abnormal production of blood cells in your bone marrow. MDS is not just one single disease. It is a group of diseases that affect how blood cells are made. In ...